ImMAGE Biotherapeutics Corporation announced that it has received $500,000 in seed round of funding from existing investor Coventry International Limited on March 9, 2016.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+6.00% | 105B | |
-4.43% | 64.68B | |
+53.33% | 43.21B | |
+17.94% | 39.33B | |
+6.75% | 32.99B | |
+12.00% | 20.09B | |
+14.15% | 17.05B | |
+24.53% | 15.96B | |
+7.25% | 14.69B |
- Stock Market
- Equities
- IMMG Stock
- News Immage Biotherapeutics Corp.
- Immage Biotherapeutics Corp. announced that it has received $0.5 million in funding from Coventry International Limited